1. Yugeesh RL, Roger GE, Bellom R, Clive NM (2019). In: Ronco C, Bellomo R, Kellum JA, Ricci Z (eds) Vasoactive Drugs, Renal Function, and Acute Kidney Injury, 3rd edn. Elsevier, Netherlands. https://doi.org/10.1016/B978-0-323-44942-7.00225-9
2. United States Food and Drug Administration (2022) FDA approves treatment to improve kidney function in adults with hepatorenal syndrome.[online] available at https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-improve-kidney-function-adults-hepatorenal-syndrome. Accessed 17 Apr 2024
3. National Center for Biotechnology Information. PubChem Compound Database; CID = 72081.Available at https://pubchem.ncbi.nlm.nih.gov/compound/Terlipressin. Accessed 16 Apr 2024
4. Food and Drug Administration database (2024) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022231s000lbl.pdf. Accessed 17 Apr 2024
5. Praveen KM, Sreeramulu J (2010) Stability indicating RP-HPLC method for simultaneous determination of terlipressin in pure and pharmaceutical formulation. J Chem Pharm Res 2(3):424–434